<DOC>
	<DOC>NCT02815748</DOC>
	<brief_summary>The purpose of the study is to investigate the Metabolite identification and material balance of SP2086 in healthy adult volunteers.</brief_summary>
	<brief_title>The Metabolite Identification and Material Balance Study of SP2086</brief_title>
	<detailed_description>All subjects were given SP2086 100mg only one time, and blood sample should be collected before and 96 hours after medicine taken.</detailed_description>
	<criteria>Healthy volunteers with a body mass index(BMI) between 19 and 25 Kg/m2,and weight â‰¥50kg. Lab and other examination results were normal or mildly abnormal without clinical significance, clinical doctors had considered eligible. Had signed the informed consent himself or herself voluntarily. Has a history of severe system disease, or family history (including the cardiovascular system, digestive system, urinary system, etc.). Has a history of allergy or intolerance to SP2086 OR other DPPIV. The subjects participated 3 times or more than 3 times drug clinical subjects in nearly a year;participate any drug clinical trial prior to the test 3 months, or had blood donor, or plan to blood donors three months before the test;or had a transfusion in 4 weeks. Did not take effective contraceptive measures or planning of the subjects in half a year. Researchers considered the patient adherence is poor, or has any unfavorable factors that not suit to participate the test.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>SP2086</keyword>
	<keyword>Metabolite identification</keyword>
	<keyword>Material balance</keyword>
</DOC>